Jiangsu Huiju Pharmaceutical

Jiangsu Huiju Pharmaceutical is a China-based integrated pharmaceutical company specializing in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The company operates as a Contract Development and Manufacturing Organization (CDMO), providing services that span from process optimization and pilot-scale production to large-scale commercial manufacturing under GMP standards. Their product portfolio primarily focuses on small molecule therapeutics across various therapeutic areas, including cardiovascular health, metabolic disorders, and anti-infectives. With a strong emphasis on regulatory compliance, Huiju Pharmaceutical serves both domestic Chinese markets and international pharmaceutical clients.